1. Home
  2. AXSM vs AQN Comparison

AXSM vs AQN Comparison

Compare AXSM & AQN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • AQN
  • Stock Information
  • Founded
  • AXSM 2012
  • AQN 1988
  • Country
  • AXSM United States
  • AQN Canada
  • Employees
  • AXSM N/A
  • AQN N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • AQN Electric Utilities: Central
  • Sector
  • AXSM Health Care
  • AQN Utilities
  • Exchange
  • AXSM Nasdaq
  • AQN Nasdaq
  • Market Cap
  • AXSM 4.2B
  • AQN 3.4B
  • IPO Year
  • AXSM 2015
  • AQN 1998
  • Fundamental
  • Price
  • AXSM $137.75
  • AQN $4.96
  • Analyst Decision
  • AXSM Strong Buy
  • AQN Hold
  • Analyst Count
  • AXSM 14
  • AQN 7
  • Target Price
  • AXSM $158.93
  • AQN $5.93
  • AVG Volume (30 Days)
  • AXSM 1.1M
  • AQN 9.2M
  • Earning Date
  • AXSM 02-18-2025
  • AQN 03-07-2025
  • Dividend Yield
  • AXSM N/A
  • AQN 5.26%
  • EPS Growth
  • AXSM N/A
  • AQN N/A
  • EPS
  • AXSM N/A
  • AQN N/A
  • Revenue
  • AXSM $385,693,000.00
  • AQN $2,614,452,000.00
  • Revenue This Year
  • AXSM $45.18
  • AQN N/A
  • Revenue Next Year
  • AXSM $65.22
  • AQN N/A
  • P/E Ratio
  • AXSM N/A
  • AQN N/A
  • Revenue Growth
  • AXSM 42.53
  • AQN 1.88
  • 52 Week Low
  • AXSM $64.11
  • AQN $4.19
  • 52 Week High
  • AXSM $139.13
  • AQN $6.79
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 74.55
  • AQN 68.87
  • Support Level
  • AXSM $124.04
  • AQN $4.41
  • Resistance Level
  • AXSM $130.52
  • AQN $4.63
  • Average True Range (ATR)
  • AXSM 5.78
  • AQN 0.15
  • MACD
  • AXSM 1.11
  • AQN 0.05
  • Stochastic Oscillator
  • AXSM 96.07
  • AQN 87.50

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp, a parent company of Liberty, is a diversified international generation, transmission, and distribution utility with over $16 billion of total assets. Through its two business groups, the Regulated Services Group and the Renewable Energy Group, AQN is committed to providing safe, secure, reliable, cost-effective, and sustainable energy and water solutions through its portfolio of electric generation, transmission, and distribution utility investments to over one million customer connections, largely in the United States and Canada. AQN provides renewable energy through its portfolio of long-term contracted wind, solar, and hydroelectric generating facilities.

Share on Social Networks: